Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Net Cash Flow (2012 - 2026)

Kamada's (KMDA) quarterly Net Cash Flow came in at -$3.5 million in Q2 2026, up 65.68% on a YoY basis from -$2.1 million in Q2 2025, and up 91.81% quarter-over-quarter from -$42.3 million in Q1 2026.

Analysis

Kamada (KMDA) Net Cash Flow (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Net Cash Flow for 15 consecutive years, with -$3.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow rose 65.68% year-over-year to -$3.5 million; the trailing twelve-month figure through Jun 2026 stood at -$36.1 million (down 472.82% YoY), and the FY2025 full-year result was -$2.7 million, down 111.74% from the prior year.
  • Net Cash Flow climbed to -$3.5 million in Q2 2026 per KMDA's latest filing, from -$42.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $30.5 million in Q3 2023 and bottomed at -$42.3 million in Q1 2026.
  • Historically, Net Cash Flow has averaged $612666.7 across 5 years, with a median of $2.7 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Net Cash Flow soared 1787.74% in 2023, then tumbled 1768.71% in 2026.
  • Over 5 years, Net Cash Flow stood at $2.9 million in 2022, then declined by 11.68% to $2.6 million in 2023, then soared by 164.71% to $6.8 million in 2024, then sank by 46.62% to $3.6 million in 2025, then tumbled by 196.07% to -$3.5 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$3.5 million, -$42.3 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -496,000.00
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -170.75 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn -3.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.47 Mn
Mar 31, 2026 -42.35 Mn
Dec 31, 2025 3.61 Mn
Sep 30, 2025 6.07 Mn
Jun 30, 2025 -10.11 Mn
Mar 31, 2025 -2.27 Mn
Dec 31, 2024 6.77 Mn
Sep 30, 2024 15.30 Mn
Jun 30, 2024 8.28 Mn
Mar 31, 2024 -7.40 Mn
Dec 31, 2023 2.56 Mn
Sep 30, 2023 30.49 Mn
Jun 30, 2023 -5.09 Mn
Mar 31, 2023 -6.83 Mn
Dec 31, 2022 2.89 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 7.81 Mn
Mar 31, 2022 3.14 Mn
Dec 31, 2021 -81.01 Mn
Sep 30, 2021 31.60 Mn